Fowler's solution: Difference between revisions
imported>Mfernflower No edit summary |
Added period name |
||
| Line 1: | Line 1: | ||
'''Fowler's solution''' consists of 1% [[potassium arsenite]] (KAsO<sub>2</sub>) in water and was first described and published as a potential treatment for [[malaria]] and [[syphilis]] in the late 1700s and was once also prescribed as a [[Pharmaceutical drug#For nutrition|tonic]].<ref>{{Cite journal |last1=Ho |first1=Derek |last2=Lowenstein |first2=Eve J. |date=2016 |title=Fowler's Solution and the Evolution of the Use of Arsenic in Modern Medicine|journal=Skinmed |volume=14 |issue=4 |pages=287–289 |issn=1540-9740 |pmid=27784519}}</ref><ref name=Jolliffe>{{cite journal | author = Jolliffe, D. M. | title = A history of the use of arsenicals in man | journal = Journal of the Royal Society of Medicine | year = 1993 | volume = 86 | issue = 5 | pages = 287–289 | doi = 10.1177/014107689308600515 | pmc = 1294007 | pmid=8505753}}</ref> Thomas Fowler (1736–1801) of [[Stafford]], England, proposed the solution in 1786 as a substitute for a [[patent medicine]], "tasteless [[fever|ague]] drop". From 1865, Fowler's solution was a [[leukemia]] treatment.<ref name=Jolliffe/><ref name=Doyle>{{cite journal | author = Doyle, Derek | title = Notoriety to respectability: a short history of arsenic prior to its present day use in haematology | journal = British Journal of Haematology | year = 2009 | volume = 145 | issue = 3 | pages = 309–317 | doi = 10.1111/j.1365-2141.2009.07623.x | pmid = 19298591 | s2cid = 6676910 | doi-access = free }}</ref> | '''Fowler's solution''' consists of 1% [[potassium arsenite]] (KAsO<sub>2</sub>) in water and was first described and published as a potential treatment for [[malaria]] and [[syphilis]] in the late 1700s and was once also prescribed as a [[Pharmaceutical drug#For nutrition|tonic]].<ref>{{Cite journal |last1=Ho |first1=Derek |last2=Lowenstein |first2=Eve J. |date=2016 |title=Fowler's Solution and the Evolution of the Use of Arsenic in Modern Medicine|journal=Skinmed |volume=14 |issue=4 |pages=287–289 |issn=1540-9740 |pmid=27784519}}</ref><ref name=Jolliffe>{{cite journal | author = Jolliffe, D. M. | title = A history of the use of arsenicals in man | journal = Journal of the Royal Society of Medicine | year = 1993 | volume = 86 | issue = 5 | pages = 287–289 | doi = 10.1177/014107689308600515 | pmc = 1294007 | pmid=8505753}}</ref> Thomas Fowler (1736–1801) of [[Stafford]], England, proposed the solution in 1786 as a substitute for a [[patent medicine]], "tasteless [[fever|ague]] drop". It was known at the time as "Liquor Arsenicalis". From 1865, Fowler's solution was a [[leukemia]] treatment.<ref name=Jolliffe/><ref name=Doyle>{{cite journal | author = Doyle, Derek | title = Notoriety to respectability: a short history of arsenic prior to its present day use in haematology | journal = British Journal of Haematology | year = 2009 | volume = 145 | issue = 3 | pages = 309–317 | doi = 10.1111/j.1365-2141.2009.07623.x | pmid = 19298591 | s2cid = 6676910 | doi-access = free }}</ref> | ||
From 1905, inorganic arsenicals like Fowler's solution saw diminished use as attention turned to organic arsenicals, starting with [[Atoxyl]].<ref name='ITOM'>{{Cite book |last1=Gibaud |first1=Stéphane |last2=Jaouen |first2=Gérard |title=Arsenic - based drugs: from Fowler's solution to modern anticancer chemotherapy |year=2010 |volume=32 |pages=1–20 |doi= 10.1007/978-3-642-13185-1_1|series=Topics in Organometallic Chemistry |bibcode=2010moc..book....1G |isbn=978-3-642-13184-4 }}</ref> | From 1905, inorganic arsenicals like Fowler's solution saw diminished use as attention turned to organic arsenicals, starting with [[Atoxyl]].<ref name='ITOM'>{{Cite book |last1=Gibaud |first1=Stéphane |last2=Jaouen |first2=Gérard |title=Arsenic - based drugs: from Fowler's solution to modern anticancer chemotherapy |year=2010 |volume=32 |pages=1–20 |doi= 10.1007/978-3-642-13185-1_1|series=Topics in Organometallic Chemistry |bibcode=2010moc..book....1G |isbn=978-3-642-13184-4 }}</ref> | ||
Latest revision as of 08:12, 13 December 2025
Fowler's solution consists of 1% potassium arsenite (KAsO2) in water and was first described and published as a potential treatment for malaria and syphilis in the late 1700s and was once also prescribed as a tonic.[1][2] Thomas Fowler (1736–1801) of Stafford, England, proposed the solution in 1786 as a substitute for a patent medicine, "tasteless ague drop". It was known at the time as "Liquor Arsenicalis". From 1865, Fowler's solution was a leukemia treatment.[2][3]
From 1905, inorganic arsenicals like Fowler's solution saw diminished use as attention turned to organic arsenicals, starting with Atoxyl.[4]
As inorganic arsenic compounds are notably toxic and carcinogenic—with side effects such as cirrhosis of the liver, idiopathic portal hypertension, urinary bladder cancer, and skin cancers—Fowler's solution fell from use. In 2001, however, the U.S. Food and Drug Administration (FDA) approved a drug of arsenic trioxide to treat acute promyelocytic leukaemia,[5] and interest in arsenic chemistry has returned.[6]
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".